Alinity 07P9020Recalls & reported problems
Abbott Ireland Diagnostics · Alinity i AFP Reagent Kit 200 Tests · Class 3
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380740130817), received between May 5, 2021 and Mar 10, 2025 — classified as 3 malfunctions.
The most frequently reported specific device problem is “High Test Results” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- High Test Results2
- Low Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 10, 2025High Test Results; High Test Results
THE CUSTOMER OBSERVED A FALSELY ELEVATED ALINITY I AFP RESULTS FOR ONE PATIENT. THE PATIENT WAS REPEATED ON MULTIPLE INSTRUMENTS WITH LOWER RESULTS. THE FOLLOWING DATA WAS PROVIDED: (AFP REFERENCE VALUE AT FACILITY: 0.9-8.8 NG/ML) SID (B)(6) INITIAL ALINITY AFP RESULT PROCESSED ON (B)(6) 2025 ON SERIAL NUMBER (B)(6) = 39.50 NG/ML RETESTED ON (B)(6) 2025 ON (B)(6) = <2.0 NG/ML AND ON (B)(6) = <2.00 NG/ML NEW SPECIMEN SAME PATIENT SID (B)(6) PROCESSED ON (B)(6) 2025 RESULTS FROM ALINITY I INSTRUMENT SERIAL NUMBER (B)(6) = <2.00 NG/ML AND <2.00 NG/ML AND PROCESSED ON (B)(6) = <2.0 NG/ML NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21561728 ↗MalfunctionMar 3, 2025High Test Results; High Test Results
THE CUSTOMER REPORTED FALSELY ELEVATED ALINITY I AFP GENERATED FROM ALINITY I PROCESSING MODULE AND PROVIDED THE FOLLOWING DATA: CUSTOMER NORMAL RANGE: 0.9 - 8.8 UG/L. (B)(6): SAMPLE ID: (B)(6), (PATIENT FROM HEALTH SCREENING). 1ST RUN (B)(6): 13.4, 2ND RUN (B)(6): 2.6, 3RD RUN (B)(6): 2.6. ON (B)(6): SAMPLE ID: (B)(6), (PATIENT FROM ENT CLINIC). 1ST RUN (B)(6): 11.7, 2ND RUN (B)(6): 8.0, 3RD RUN (B)(6): 7.4. ON (B)(6): SAMPLE ID: (B)(6), (PATIENT FROM GASTROINTESTINAL CLINIC). 1ST RUN (B)(6): 26. 2ND RUN (B)(6): 2.9. 3RD RUN (B)(6): 3.3. NO OTHER PATIENT INFORMATION WAS PROVIDED. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21509097 ↗MalfunctionMay 5, 2021Low Test Results; Low Test Results
THE CUSTOMER REPORTED A FALSELY DECREASED ALINITY I AFP RESULT ON A PATIENT. RESULTS PROVIDED: (B)(6) 2021 SID (B)(6) = 13 / > 1660 / > 1660 / X10 DILUTION = 5823 / 5800 IU/ML. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11778278 ↗
Other KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS devices
- ARCHITECT 3P36-25Abbott Ireland Diagnostics · KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS20 reports
- ADVIA Centaur® AFP 10309980Siemens Healthcare Diagnostics Inc. · Kit, Test, Alpha-Fetoprotein For Neural Tube Defects19 reports
- ADVIA Centaur® AFP 10309979Siemens Healthcare Diagnostics Inc. · Kit, Test, Alpha-Fetoprotein For Neural Tube Defects19 reports
- ARCHITECT 3P36-35Abbott Ireland Diagnostics · KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS10 reports
- Alinity 07P9030Abbott Ireland Diagnostics · KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS5 reports
- IMMULITE® 2000 Systems AF AFP 10381187Siemens Healthcare Diagnostics Products Ltd · Kit, Test, Alpha-Fetoprotein For Neural Tube Defects3 reports
- Access AFP 33211Beckman Coulter, Inc. · Kit, Test, Alpha-Fetoprotein For Neural Tube Defects1 report
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.